Clinical Trials
5 trialsNCT03816345 2026-06-11
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT02450396 2026-03-27
EGR2
Assistance Publique - Hôpitaux de Paris
Withdrawn
NCT07290946 2025-12-18
MESRIX-more
Rigshospitalet, Denmark
Phase 2 Not yet recruiting
NCT07249060 2025-12-03
INTER-AUTENTIC
Hospital Universitario Araba
Recruiting
NCT02422875 2025-09-30
Comparative Autoantibody and Immunologic Cell Marker Study
Emory University
Enrolling by invitation